NEW YORK, March 03, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of MiMedx Group Inc. ("MiMedx") (NASDAQ:MDXG) between March 7, 2013 and February 21, 2018. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. To get more information go to:
http://www.zlk.com/pslra-d/mimedx-group-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) MiMedx was engaged in a “channel-stuffing” scheme designed to inappropriately recognize revenue that had not yet been realized; (ii) the Company lacked adequate internal controls over financial reporting; and (iii) that as a result of the foregoing, MiMedx’s publicly disseminated financial statements were materially false and misleading.
On February 20, 2018, MiMedx announced that it would postpone the release of its financial results and Form 10-K filing for 2017. MiMedx stated it had engaged “independent legal and accounting advisors to conduct an internal investigation into current and prior-period matters relating to the allegations regarding certain sales and distribution practices at the Company.” Following this news, shares of MiMedx fell from a close of $14.47 per share on February 16, 2018 to a close of $8.75 on February 20, 2018.
If you suffered a loss in MiMedx you have until April 25, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 



